SAN ANTONIO, TX / ACCESS Newswire / November 19, 2026 / Valion Bio, Inc. (NASDAQ: VBIO) ("Valion" or the "Company"), a clinical-stage ...
News
- Valion Bio Welcomes Former U.S. Army Regulatory Leader and Biotech CEO Dr. Armand ...
- Specialized airway surgery at UT Health San Antonio Multispecialty and Research Hospital ...
SAN ANTONIO, Nov. 19, 2026 – For nearly two years, the simple act of ... biomedical sciences and public health that are leading change and ...
- Valion Bio Welcomes Former U.S. Army Regulatory Leader and Biotech CEO Dr. Armand ...
SAN ANTONIO, TX / ACCESS Newswire / November 19, 2026 / Valion Bio, Inc. (NASDAQ:VBIO) ("Valion" or the "Company"), a clinical-stage ...
- Valion Bio Welcomes Former U.S. Army Regulatory Leader and Biotech CEO Dr. Armand ... - t.co / X
SAN ANTONIO, TX / ACCESS Newswire / November 19, 2026 / Valion Bio, Inc. (NASDAQ:VBIO) ("Valion" or the "Company"), a clinical-stage b.
- nChroma Bio cuts staff by half after halting its only clinical-stage drug - Boston Business Journal
Boston biotech nChroma Bio is halting its only clinical ... San Antonio · San Francisco · Seattle · Silicon Valley · St. Louis · Tampa Bay ...
